95789-69-8

Basic information

• Product Name: cyclohexyl (1-iodoethyl)carbonate
• CAS NO: 95789-69-8
• Molecular Weight: 298.121
• Mol File: 95789-69-8.mol
• Article Data: 12

Chemical Properties

• CAS DataBase Reference: cyclohexyl (1-iodoethyl)carbonate(CAS DataBase Reference)
• NIST Chemistry Reference: cyclohexyl (1-iodoethyl)carbonate(95789-69-8)
• EPA Substance Registry System: cyclohexyl (1-iodoethyl)carbonate(95789-69-8)

Safety Data

• Hazardous Substances Data: 95789-69-8(Hazardous Substances Data)

Upstream product

• 108-93-0 cyclohexanol 
• 13248-54-9 cyclohexyl chloroformate 
• 99464-83-2 1-chloroethyl cyclohexyl carbonate 

Downstream Products

• 145040-37-5 candesartan cilexetil 
• 1158510-12-3 1-(cyclohexyloxycarbonyloxy)ethyl (1R,5S,6S)-2-[(1-(4-fluorobenzyl)azetidin-3-yl)thio]-6-[(R)-1-hydroxyethyl]-1-methyl-carbapen-2-em-3-carboxylate 
• 1026789-25-2 (S)-3-aminomethyl-5-methyl-hexanoic acid 1-cyclohexyloxycarbonyloxy-ethyl ester trifluoroacetate 
• 156113-99-4 4'-[(2-n-Propyl-4-methyl-6-(5,6,7,8-tetrahydro-imidazo[1,2-a]pyridin-2-yl)-benzimidazol-1-yl)-methyl]-2-[1-(cyclohexyloxycarbonyloxy)-ethyloxycarbonyl]-biphenyl 
• 139307-63-4 (+)-(5R,6S)-6-[(R)-1-hydroxyethyl]-3-(3-pyridyl)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid 1-(cyclohexyloxycarbonyloxy)ethyl ester 
• 258835-95-9 1-(Cyclohexyloxycarbonyloxy)ethyl(1S,5R,6S)-2-(7-hydroxyacetylimidazo[5,1-b]thiazol-2-yl)-6-((1R)-1-hydroxyethyl)-1-methyl-1-carbapen-2-em-3-carboxylate 
• 258835-86-8 1-(Cyclohexyloxycarbonyloxy)ethyl(1S,5R,6S)-6-((1R)-1-hydroxyethyl)-2-(7-methanesulfonylimidazo[5,1-b]thiazol-2-yl)-1-methyl-1-carbapen-2-em-3-carboxylate 
• 258838-09-4 1-(Cyclohexyloxycarbonyloxy)ethyl(1S,5R,6S)-6-((1R)-1-hydroxyethyl)-1-methyl-2-(7-methylthioimidazo[5,1-b]thiazol-2-yl)-1-carbapen-2-em-3-carboxylate 
• 258836-12-3 1-(Cyclohexyloxycarbonyloxy)ethyl(1S,5R,6S)-2-[7-(N,N-dimethylsulfamoyl)imidazo[5,1-b]thiazol-2-yl]-6-((1R)-1-hydroxyethyl)-1-methyl-1-carbapen-2-em-3-carboxylate 
• 258836-04-3 1-(Cyclohexyloxycarbonyloxy)ethyl(1S,5R,6S)-2-[7-(N,N-dimethylcarbamoyl)acetylimidazo[5,1-b]thiazol-2-yl]-6-((1R)-1-hydroxyethyl)-1-methyl-1-carbapen-2-em-3-carboxylate 
• 258835-77-7 1-(Cyclohexyloxycarbonyloxy)ethyl(1S,5R,6S)-2-(7-N-acetylaminomethylimidazo[5,1-b]thiazol-2-yl)-6-((1R)-1-hydroxyethyl)-1-methyl-1-carbapen-2-em-3-carboxylate 
• 258836-82-7 1-(Cyclohexyloxycarbonyloxy)ethyl(1S,5R,6S)-6-((1R)-1-hydroxyethyl)-2-(7-methanesulfonyl-5-methylimidazo[5,1-b]thiazol-2-yl)-1-methyl-1-carbapen-2-em-3-carboxylate 
• 258836-93-0 1-(Cyclohexyloxycarbonyloxy)ethyl(1S,5R,6S)-2-(7-acetyl-5-methylimidazo[5,1-b]thiazol-2-yl)-6-((1R)-1-hydroxyethyl)-1-methyl-1-carbapen-2-em-3-carboxylate 

Relevant articles and documents

Preparation method of high-purity cefotiam hexetil dihydrochloride

The invention discloses a preparation method of cefotiam hexetil dihydrochloride. The method comprises the steps that cefotiam hydrochloride is used as a raw material for synthesizing cefotiam alkali metal salt; the cefotiam alkali metal salt and 1-iodoet

GABA ANALOGS, COMPOSITIONS, AND METHODS FOR MANUFACTURING THEREOF

The invention provides novel compounds of Formula (I), pharmaceutical compositions and methods of synthesis thereof.

GABA ANALOGS, COMPOSITIONS AND METHODS FOR MANUFACTURING THEREOF

The invention provides novel compounds of Formula (I), pharmaceutical compositions and methods of synthesis thereof.